Trial Profile
Claims Database Study of Utilization Patterns of Dimethyl Fumarate in Germany
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2017
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Biogen
- 23 Jun 2017 Status changed from active, no longer recruiting to completed.
- 08 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 23 Nov 2016 New trial record